News

RegMed XB has received the first subsidy of 23 million euros from the Ministry of Economic Affairs and Climate Policy. This is the start of the realization of the national pilot factory for regenerative medicine after the Dutch cabinet decided on 9 April this year to fund the National Growth Fund...

The first ICAI Lab in the region – the ICAI Brightlands Smart Health Lab – is committed to making breakthroughs in patient care by developing and deploying artificial intelligence.

The only way to get enough people to quit smoking to achieve the goals of the National Prevention Agreement is to substantially increase the excise duty on tobacco products. This is the conclusion of research by Maastricht University (UM) on the price sensitivity of people who smoke cigarettes or...

Two talented young researchers from the Faculty of Health, Medicine and Life Sciences (FHML) at Maastricht University have won awards. Kim Kampen received the KNAW Early Career Award and Floor van den Brand has won the Catharina Pijls Dissertation Prize.

Chlamydia is the most common bacterial sexually transmitted disease (STD) worldwide and in the Netherlands. The clinical and public health relevance of widespread case finding by testing for asymptomatic Chlamydia infections is under debate.